Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Addressing adverse events through clinical indicators.

R Portelli1, B Collopy, P Desmond

  • 1Australian Council on Healthcare Standards Care Evaluation Program, Aikenhead Centre, Fitzroy, Vic.

Journal of Quality in Clinical Practice
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of Brain Iron in Niemann-Pick Type C: A 7T Quantitative Susceptibility Mapping Study.

AJNR. American journal of neuroradiology·2023
Same author

Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline.

The journal of nutrition, health & aging·2020
Same author

Influence of food and lifestyle on the risk of developing inflammatory bowel disease.

Internal medicine journal·2016
Same author

Treatment of refractory stomal variceal haemorrhage with embolisation and sclerosis.

Internal medicine journal·2015
Same author

Preoperative magnetic resonance spectroscopy improves diagnostic accuracy in a series of neurosurgical dilemmas.

British journal of neurosurgery·2013
Same author

Androgenic-anabolic steroid drug-induced liver injury.

Internal medicine journal·2013
Same journal

Phenomenon of quality and health-care.

Journal of quality in clinical practice·2002
Same journal

Aspects of the Pharmaceuticals Benefits Scheme.

Journal of quality in clinical practice·2002
Same journal

Rational prescribing for childhood pneumonia.

Journal of quality in clinical practice·2002
Same journal

Quality management and the Emergency Services Enhancement Program.

Journal of quality in clinical practice·2002
Same journal

Eradicating Helicobacter pylori in patients with a past history of peptic ulcer: is the juice worth the squeeze?

Journal of quality in clinical practice·2002
Same journal

Ensuring accuracy of clinical data is only part of the audit process.

Journal of quality in clinical practice·2002
See all related articles

To enhance patient safety, new clinical indicators for adverse drug reactions were developed and tested. Six indicators will be implemented to improve healthcare standards and reporting by January 1999.

Area of Science:

  • Pharmacovigilance
  • Healthcare Quality Improvement
  • Clinical Indicators

Background:

  • Adverse drug reactions (ADRs) pose significant risks, including morbidity, mortality, and financial costs.
  • Improving the reporting rate of ADRs is crucial for patient safety and effective healthcare.
  • Existing healthcare standards require enhancement to address ADRs more effectively.

Purpose of the Study:

  • To develop and field-test clinical indicators for adverse drug reactions.
  • To improve healthcare standards by increasing clinical staff awareness of ADR implications.
  • To establish achievable and relevant measures for monitoring ADRs in clinical practice.

Main Methods:

  • The Adverse Drug Reaction Advisory Committee collaborated with the Australian Council on Healthcare Standards Care Evaluation Program.

Related Experiment Videos

  • Ten clinical indicators were developed, focusing on ADR reporting, anaphylaxis protocols, warfarin, and streptokinase monitoring.
  • Field testing of these indicators was conducted in ten Australian health-care organizations.

    • Main Results:

    • Data availability, clinical relevance, and achievability of the indicators were assessed during field testing.
    • The field test provided valuable insights into the practical application of the proposed indicators.
    • Six adverse drug reaction clinical indicators were validated for implementation.

    Conclusions:

    • The developed clinical indicators are relevant and achievable for improving ADR reporting and healthcare standards.
    • Six ADR clinical indicators will be integrated into the Australian Council on Healthcare Standards Evaluation and Quality Improvement Program.
    • Implementation of these indicators is expected to enhance patient safety and reduce the impact of adverse drug reactions.